×
Product Info Description
Product Info Description
Strength: 10 mg CAS: 170851-70-4 Chemical Formula: C38H49N9O5 Molecular weight: 711.9 g/mol Peptide Sequence: Aib–His-D-2Nal-D-Phe-Lys Synonyms: Ipamorelin Acetate Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light. Shelf life: 24 months from the manufacturing date.
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue that interacts with the ghrelin receptor (GHS R1a) in experimental systems. Research suggests that it can stimulate growth hormone release via GHS R1a, allowing researchers to study receptor specificity, endocrine signaling pathways, and peptide–receptor interactions in controlled laboratory models.
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
Browse Products
INFORMATION
What is Ipamorelin (10mg)?
Ipamorelin is a synthetic peptide classified as a growth hormone secretagogue (GHS) within endocrine research. It is commonly studied for its selective interaction with the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
In laboratory research, ipamorelin is used to examine regulated growth hormone signaling, receptor binding, and downstream cellular signaling. Its defined structure and receptor selectivity make it ideal for controlled experimental models focusing on endocrine pathway analysis.
This product is intended solely for laboratory research use.
Product Specifications
CAS Number: 170851-70-4 Peptide Sequence: Aib–His-D-2Nal-D-Phe-Lys Chemical Formula: C38H49N9O5 Molecular Weight:711.9 g/mol Purity: ≥99% Packaging Format: 10mg lyophilized vial Storage Conditions: Store at -20°C, avoid light exposure Designation: For Laboratory Research Use Only
Key Characteristics of Ipamorelin (10mg)
Synthetic growth hormone secretagogue with a defined molecular structure. High purity (≥99%), suitable for reproducible laboratory experiments. Selectively interacts with ghrelin (GHS-R1a) receptors in research models. Frequently examined in endocrine and metabolic signaling studies. Supplied in lyophilized format for research flexibility. Requires low-temperature storage to maintain molecular stability. Not approved for diagnostic, therapeutic, or clinical use.
How Ipamorelin (10mg) Supports Research
Ipamorelin is widely used in laboratory research to study receptor-mediated growth hormone signaling. By selectively binding to the ghrelin receptor in experimental systems, researchers can evaluate hormone release dynamics, receptor activation patterns, and intracellular signaling responses.
Its consistent structure supports controlled experimental design and comparative studies within endocrine research models.
Research Applications & Usage Information
Ipamorelin (10mg) is commonly used in laboratory research for:
Growth hormone signaling pathway investigations. Ghrelin receptor activation and binding assays. Endocrine feedback loop modeling. Peptide-receptor interaction analysis. Comparative studies with other growth hormone secretagogues. In vitro cellular signaling experiments. Metabolic regulation pathway research.
This peptide is supplied exclusively for research purposes and must be used in accordance with institutional laboratory safety standards.
Handling and Storage Recommendations
Store at −20°C immediately upon receipt. Protect from direct light exposure. Keep the vial tightly sealed when not in use. Avoid repeated freeze-thaw cycles. Handle using appropriate laboratory protective equipment. Follow standard laboratory handling and documentation procedures.
Proper storage and careful handling help preserve peptide integrity and support consistent research outcomes.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552 National Center for Biotechnology Information. Ipamorelin. PubChem Compound Summary; CID 9831657. Accessed February 2026. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin Johansen PB, Nowak J, Skjærbæk C, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone IGF Res. 1999;9(2):106‐113. doi:10.1054/ghir.1999.9998
What is Ipamorelin (10mg)?
Ipamorelin is a synthetic peptide classified as a growth hormone secretagogue (GHS) within endocrine research. It is commonly studied for its selective interaction with the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor.
In laboratory research, ipamorelin is used to examine regulated growth hormone signaling, receptor binding, and downstream cellular signaling. Its defined structure and receptor selectivity make it ideal for controlled experimental models focusing on endocrine pathway analysis.
This product is intended solely for laboratory research use.
Product Specifications
CAS Number: 170851-70-4 Peptide Sequence: Aib–His-D-2Nal-D-Phe-Lys Chemical Formula: C38H49N9O5 Molecular Weight:711.9 g/mol Purity: ≥99% Packaging Format: 10mg lyophilized vial Storage Conditions: Store at -20°C, avoid light exposure Designation: For Laboratory Research Use Only
Key Characteristics of Ipamorelin (10mg)
Synthetic growth hormone secretagogue with a defined molecular structure. High purity (≥99%), suitable for reproducible laboratory experiments. Selectively interacts with ghrelin (GHS-R1a) receptors in research models. Frequently examined in endocrine and metabolic signaling studies. Supplied in lyophilized format for research flexibility. Requires low-temperature storage to maintain molecular stability. Not approved for diagnostic, therapeutic, or clinical use.
How Ipamorelin (10mg) Supports Research
Ipamorelin is widely used in laboratory research to study receptor-mediated growth hormone signaling. By selectively binding to the ghrelin receptor in experimental systems, researchers can evaluate hormone release dynamics, receptor activation patterns, and intracellular signaling responses.
Its consistent structure supports controlled experimental design and comparative studies within endocrine research models.
Research Applications & Usage Information
Ipamorelin (10mg) is commonly used in laboratory research for:
Growth hormone signaling pathway investigations. Ghrelin receptor activation and binding assays. Endocrine feedback loop modeling. Peptide-receptor interaction analysis. Comparative studies with other growth hormone secretagogues. In vitro cellular signaling experiments. Metabolic regulation pathway research.
This peptide is supplied exclusively for research purposes and must be used in accordance with institutional laboratory safety standards.
Handling and Storage Recommendations
Store at −20°C immediately upon receipt. Protect from direct light exposure. Keep the vial tightly sealed when not in use. Avoid repeated freeze-thaw cycles. Handle using appropriate laboratory protective equipment. Follow standard laboratory handling and documentation procedures.
Proper storage and careful handling help preserve peptide integrity and support consistent research outcomes.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552 National Center for Biotechnology Information. Ipamorelin. PubChem Compound Summary; CID 9831657. Accessed February 2026. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin Johansen PB, Nowak J, Skjærbæk C, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone IGF Res. 1999;9(2):106‐113. doi:10.1054/ghir.1999.9998